Nesina
Chemical Name | alogliptin |
Dosage Form | Tablet (oral; 6.25 mg, 12.5 mg, 25 mg) |
Drug Class | Inhibitors |
System | Endocrine |
Company | Takeda |
Approval Year | 2013 |
Indication
- Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.